Novo Nordisk has cut prices for Wegovy and Ozempic, reducing the monthly cost for new customers to $199 for two months, then $349 afterward, down from $499.This price cut aligns with efforts by Donald Trump to lower medication costs, including a deal ensuring Medicare will cover Wegovy and Zepbound at discounts on the TrumpRx website launching in 2026.David Moore of Novo Nordisk highlighted expanded distribution through outlets like Costco and noted about 25% of GLP-1 users pay out-of-pocket, emphasizing the need for affordability.